ACM
BHVN icon

Altium Capital Management’s Biohaven BHVN Stock Holding History

Altium Capital Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-250,000
Closed -$9.34M – 33
2024
Q4 		$9.34M Buy
250,000
+175,000
+233% +$8.16M 2.65% 14
2024
Q3 		$3.75M Buy
+75,000
New +$2.92M 1.1% 34
2024
Q2 		– Sell
-140,000
Closed -$7.66M – 72
2024
Q1 		$7.66M Buy
+140,000
New +$6.93M 3.03% 12
2023
Q4 		– Sell
-287,000
Closed -$7.46M – 72
2023
Q3 		$7.46M Buy
+287,000
New +$5.97M 3.89% 12
2023
Q2 		– Sell
-260,000
Closed -$3.55M – 73
2023
Q1 		$3.55M Buy
260,000
+60,000
+30% +$955K 1.97% 19
2022
Q4 		$2.78M Buy
+200,000
New +$2.82M 1.41% 28

Other funds holding BHVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Altium Capital Management's BHVN Position: Q1 2025 in Review

Altium Capital Management sold out of Biohaven (BHVN) in Q1 2025, closing a stake of 250,000 shares — an estimated $9.34M sold.

Altium Capital Management first reported a position in BHVN in Q4 2022 and held it in 6 quarters. The position peaked at $9.34M in Q4 2024. 266 funds tracked by Wall St. Rank hold BHVN as of Q1 2025.

  • Altium Capital Management reported no remaining Biohaven position as of Q1 2025 after selling out during the quarter.
  • Altium Capital Management sold 250,000 Biohaven shares in Q1 2025, an estimated $9.34M.
  • Altium Capital Management first reported a position in Biohaven in Q4 2022 and held it in 6 quarters.
  • Altium Capital Management's Biohaven position peaked at $9.34M in Q4 2024.
  • 266 funds tracked by Wall St. Rank held Biohaven as of Q1 2025.

Based on Altium Capital Management's 13F filing for Q1 2025, filed 9 May 2025.